John Dudley, MD
Interventional Cardiology · Fort Walton Beach, FLNPI 1679923254
Payments from drug & device makers
Across 139 payments — averaging $79.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$4K
- Edwards Lifesciences$2K
- Boston Scientific$2K
- Medtronic$525
- Abiomed$474
- W. L. Gore & Associates, Inc.$342
- plus $2K from 19 others
What the payments were for
- Consulting fees$2,75025%
- Travel & lodging$2,25520%
- Food & beverage$5,69551%
- Education$3713%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 15 | $3,991 |
| Edwards Lifesciences | 16 | $2,096 |
| Boston Scientific | 23 | $1,810 |
| Medtronic | 4 | $525 |
| Abiomed | 8 | $474 |
| W. L. Gore & Associates, Inc. | 2 | $342 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $236 |
| Merck | 11 | $224 |
| Pfizer | 12 | $214 |
| E.r. Squibb & Sons, L.L.C. | 5 | $200 |
| Penumbra, Inc. | 4 | $184 |
| Philips North America LLC | 2 | $173 |
| Kestra Medical Technology Services, Inc. | 5 | $104 |
| Novartis | 5 | $79 |
| AstraZeneca | 4 | $66 |
| Amgen | 3 | $56 |
| Cardiva Medical, Inc. | 2 | $50 |
| Johnson & Johnson | 3 | $45 |
| Lantheus Medical Imaging, Inc. | 2 | $43 |
| Abbott | 2 | $43 |
| Teleflex LLC | 1 | $31 |
| Biosense Webster, Inc. | 1 | $26 |
| Cvrx, Inc. | 1 | $26 |
| Biotronik Inc. | 1 | $18 |
| Scpharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$3,575
- GENERAL VASCULAR ACCESS$1,215
- Edwards SAPIEN 3 Transcatheter Heart Valve$658
- GORE CARDIOFORM Septal Occluder$342
- Impella$264
- RESOLUTE ONYX$214
- (6571) Eagle Eye$148
- Penumbra System$142
- Rhythmia Mapping System$137
- CAMZYOS$122
- Micra$120
- PASCAL$113
- COREVALVE EVOLUT R$107
How this compares
$11,071 in reported general payments places this provider in the 50th percentile of 623 interventional cardiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 140 | $125,382 |
| EntrestoSacubitril/Valsartan | 116 | $120,647 |
| XareltoRivaroxaban | 16 | $10,686 |
| Metoprolol Succinate | 234 | $2,455 |
| ClopidogrelClopidogrel Bisulfate | 130 | $1,426 |
| Rosuvastatin Calcium | 69 | $935 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 15 | $762 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 15 | $537 |
| Losartan Potassium | 46 | $356 |
| Atorvastatin Calcium | 45 | $310 |
| Propranolol Hcl ErPropranolol Hcl | 12 | $280 |
| Lisinopril | 52 | $266 |
| Carvedilol | 51 | $257 |
| Potassium Chloride | 13 | $215 |
| Hydralazine Hcl | 16 | $201 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $214 | $125,382140 claims |
| NovartisEntresto | $79 | $120,647116 claims |
| Johnson & JohnsonXarelto | $45 | $10,68616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 623 interventional cardiology providers in Florida.
Other interventional cardiology in Fort Walton Beach
- Dominick AngiolilloJacksonville$4M
- Douglas SpriggsClearwater$3.2M
- Rakesh PrashadOcala$3.1M
- Aldo Martinez FleitesMiami Lakes$2.2M
- Rohit AminPensacola$2M
- Roberto CubedduNaples$2M
- Arthur LeeGainesville$2M
- Ruby SatpathyJacksonville$1.8M
- Santhosh MathewsBradenton$1.7M
- Pedro Martinez-ClarkMiami$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.